Breast Reduction Free Nipple Incision in Salvador Brazil
Breast reduction is an operation that is usually considered a reconstructive procedure and is many times covered by insurance plans. The surgery is performed to make the breasts smaller, as well as lift the breasts to a more youthful position. The purpose of the surgery is to alleviate back and neck pain as well as to aid in hygiene in the folds underneath the breasts.
Marks are made on the skin according to the type of reduction planned by the patient and the surgeon. This is usually performed before the patient is taken back to the operating room with the patient in a sitting or standing position.
The nipple-areola section of skin is removed and saved.
Excess skin and breast tissue is removed.
The incisions are closed with sutures and the nipple-areola skin is reattached.
The patient is placed in a compression garment or bra. Compression garments are an important part of the recovery process. The garment provides support, comfort and helps to minimize swelling. The patient is usually wearing a bra or some type of supportive garment at all times, except when showering. Healing time is approximately three months. Scarring is variable and often depends on the patient's ability to heal.
More Salvador info...
Salvador Sleep
Salvador's lodging options are basically divided between the hotels in the Cidade Alta and those in the beach districts. There are also hostels in Pelourinho that are reasonably priced, but noisy at night.
Sao Jorge [1], in Pelourinho, charges 50 Real a night for a double room (May 2006).
Amaralina Praia, Av. Otavio Mangabeira 197, 248-9998. Located in the southernmost beach district, so you'll need to take a taxi to get into the old town. Not the best choice for a good night's sleep, as the open-air bar next door can be noisy. -
Salvador Understand Salvador de Bahia-
Plastic Surgery News...
- University of Alberta researchers in Edmonton, Canada, have developed a portable unit for genetic testing about the size of a shoebox, which has the same capability as a lab full of expensive equipment.The device - along with other, even smaller units the team is now in the process of developing - paves the way for enormous savings to health-care systems and will improve care for patients.
- It is estimated that 80% or more of drugs used in Europe and the US to treat children with cancer do not have information for paediatric use in their product licence and are thus used off-label. The Paediatric Regulation, which came into effect on Jan 2007, aimed to provide better drugs for children by increasing the amount of high-quality ethical research done in children and by ensuring the availability of authorised paediatric drugs and proper information on their uses. The Task Force in Europe for Drug Development for the Young (TEDDY) project and societies, such as the International Society for Paediatric Oncology–Europe (SIOP–E), intend to aid this initiative. This paper deals with the issues encountered in the management of children with cancer, the barriers to overcome, and the potential solutions, specifically:
• Central issue of clinical research
• Role of paediatric pharmacovigilance
• Current situation and future perspectives
• Effects of the new Paediatric Regulation